# US Cancer Registry Software Market > US Cancer Registry Software Market Research Report By Deployment Type (On-Premise, Cloud-Based, Web-Based), By Application (Data Collection, Data Management, Analysis and Reporting, Patient Monitoring), By End User (Hospitals, Research Institutions, Government Organizations, Cancer Treatment Centers) and By Software Type (Integrated Software, Standalone Software, Custom Software) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.11% - **2024:** $ 590.82 Million - **2025:** $ 632.83 Million - **2035:** $ 1,257.72 Million - **Key Players:** Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), IBM Watson Health (US), Oracle Corporation (US), Allscripts Healthcare Solutions (US), Varian Medical Systems (US), Siemens Healthineers (DE) **Report ID:** MRFR/HC/12276-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-cancer-registry-software-market-13801 --- ## Market Summary ## **US Cancer Registry Software Market Overview** As per MRFR analysis, the US Cancer Registry Software Market Size was estimated at 551.6 (USD Million) in 2023. The US Cancer Registry Software Market Industry is expected to grow from 590.8(USD Million) in 2024 to 1,785 (USD Million) by 2035. The US Cancer Registry Software Market CAGR (growth rate) is expected to be around 10.574% during the forecast period (2025 - 2035). ### **Key US Cancer Registry Software Market Trends Highlighted** The US Cancer Registry Software Market is experiencing notable trends driven by several factors. One of the key market drivers is the increasing prevalence of cancer cases across the country, prompting healthcare facilities to enhance their data management systems. The National Cancer Institute notes that cancer remains one of the leading causes of mortality in the US, which has led to a heightened emphasis on comprehensive cancer registries that can capture essential data for research and treatment analysis. Additionally, the push for improved patient outcomes through enhanced data reporting and management has motivated states to adopt more sophisticated cancer registry solutions that integrate seamlessly with electronic health records. Opportunities exist in the realm of technological advancements, particularly with the adoption of artificial intelligence and machine learning within [cancer registry software](../../../reports/cancer-registry-software-market-7852). These technologies can streamline the data collection process, improve accuracy, and enable better analytics to drive evidence-based decision-making in patient care. Furthermore, state initiatives aimed at improving cancer surveillance and reporting present a ripe landscape for software developers and healthcare institutions to collaborate and innovate their offerings. In recent times, the trend towards centralized data systems has gained traction, where states are moving towards more unified and interoperable cancer registry systems to ensure data sharing and regulatory compliance. This enables more effective tracking of cancer incidence and outcomes, ultimately guiding public health strategies. The focus on standardization in reporting and data collection is also becoming increasingly important, as federal agencies call for more integrated approaches to cancer data management. As the US healthcare system continues to evolve, these trends highlight a significant shift in how cancer data is recorded, analyzed, and utilized to enhance patient care and cancer control efforts nationwide. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Cancer Registry Software Market Drivers** #### **Increasing Cancer Incidence Rates** The US Cancer Registry Software Market Industry is significantly driven by the rising incidence rates of cancer in the United States. According to the American Cancer Society, it is estimated that about 1.9 million new cancer cases were diagnosed in 2021 alone, representing a continuing upward trend in the prevalence of various types of cancer. This increase necessitates more robust and effective cancer registries to track patient information, treatment progress, and outcomes extensively. The Centers for Disease Control and Prevention (CDC) reported a 25% increase in the use of cancer registry software solutions from 2015 to 2020, emphasizing the sector's need for enhanced data management capabilities. Organizations such as the National Cancer Institute are advocating for better registry systems to ensure accurate data collection, which is crucial for advancing cancer research and public health strategies. Moreover, with the projected 12 million cancer survivors in the US by 2030, there is a critical demand for efficient data management systems. As cancer incidence continues to rise, investment in cancer registry software will increase, further fueling growth in the US Cancer Registry Software Market Industry. #### **Technological Advancements in Healthcare** The integration of advanced technologies in healthcare, such as artificial intelligence and machine learning, is driving the US Cancer Registry Software Market Industry forward. These technologies enhance the capabilities of cancer registries by enabling better data analysis, patient tracking, and reporting functionalities. According to the Health Information Management Systems Society, the adoption of advanced Health Information Technology systems in the US has seen a significant increase of 40% from 2016 to 2021. Notable organizations like Epic Systems and Cerner Corporation are leading the way in developing innovative cancer registry software that employs these cutting-edge technologies, thereby improving operational efficiency for healthcare facilities. As hospitals and cancer treatment centers increasingly lean on these state-of-the-art solutions for data management and patient care, the demand for enhanced cancer registry software will continue to surge in the US. #### **Government Regulations and Initiatives** Government regulations and initiatives related to cancer management are also a key driver of the US Cancer Registry Software Market Industry. The National Cancer Act of 1971 laid the foundation for systematic cancer research and registry establishment, leading to the continuous improvement of cancer data collection. Recent policies from the US Department of Health and Human Services have mandated enhanced reporting standards and transparency for cancer patient data. The National Program of Cancer Registries (NPCR) has contributed to a consistent increase in state cancer registry participation rates by over 30% since its inception, reinforcing the necessity for advanced software solutions to meet reporting requirements. As regulatory requirements evolve, healthcare institutions will increasingly turn to advanced software options to maintain compliance, thereby propelling growth in the sector. ### **US Cancer Registry Software Market Segment Insights** #### **Cancer Registry Software Market Deployment Type Insights** The Deployment Type segment of the US Cancer Registry Software Market plays a crucial role in how healthcare providers manage and analyze cancer-related data. This segment is generally categorized into On-Premise, Cloud-Based, and Web-Based solutions, each offering unique advantages and impacting market dynamics in different ways. On-Premise solutions often provide enhanced data security, which is essential for handling sensitive patient information, making it popular among healthcare institutions that prioritize privacy. However, the rising demand for Cloud-Based solutions has been reshaping this landscape as it offers greater accessibility, scalability, and cost-effectiveness. With the growing trend of telemedicine and remote patient monitoring, Cloud-Based models are gaining traction for their ability to provide updates and support from anywhere, allowing healthcare providers to be more agile in their operations. Web-Based solutions stand out for their user-friendly interfaces and ease of integration with various hospital systems, which facilitates seamless data sharing and collaboration among oncology care teams. These web-based applications often enable real-time analytics and decision-making, enhancing patient outcomes by allowing healthcare professionals to stay updated on the most current treatment protocols and research findings. In this competitive landscape, the demand for innovative and efficient Cancer Registry Software solutions continues to grow, driven by stricter regulatory requirements and an increasing emphasis on data-driven healthcare. The shift towards Cloud and Web-Based models reflects broader industry trends towards digital transformation, providing opportunities for developers to enhance user experience and functionality. The ongoing evolution of technology and patient care preferences suggests that the Deployment Type segment will continue to grow in significance as healthcare organizations recognize the value of flexible and efficient software solutions in managing cancer data effectively. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Cancer Registry Software Market Application Insights** The Application segment of the US Cancer Registry Software Market plays a critical role in streamlining operations and enhancing the efficiency of cancer data management. This segment encompasses essential functions such as Data Collection, Data Management, Analysis and Reporting, and Patient Monitoring, each contributing to comprehensive cancer care. Data Collection methods ensure accurate patient information, which is vital for effective treatment planning. Data Management is significant as it facilitates the organization and retrieval of vast amounts of clinical data, thus supporting healthcare professionals in making informed decisions. Analysis and Reporting features are crucial for generating insights from collected data, helping in research and improving patient outcomes. Meanwhile, Patient Monitoring tools aid in tracking patient progress and managing follow-ups, making them indispensable in cancer treatment. With the increasing emphasis on data-driven decision-making in healthcare, the Application segment is expected to see significant growth, driven by advancements in technology and an increasing focus on patient-centered care in the US. The success of this segment underlines its importance in enhancing cancer registry functionalities and quality of care. #### **Cancer Registry Software Market End User Insights** The End User segment of the US Cancer Registry [Software Market](../../../press-release/software-market) showcases a diverse landscape that includes Hospitals, Research Institutions, Government Organizations, and Cancer Treatment Centers. Hospitals play a crucial role in patient care and data collection, as they manage vast amounts of patient information crucial for cancer tracking and outcomes assessment. Research Institutions utilize cancer registry software to facilitate studies and clinical trials, driving innovations that enhance treatment options. Government Organizations focus on public health surveillance and policy-making, leveraging data to improve cancer control programs and resource allocation. Meanwhile, Cancer Treatment Centers are pivotal in managing patient treatment journeys and outcomes, providing insights that guide clinical practices. This End User segment is instrumental in driving the overall performance of the US Cancer Registry Software Market, as each entity contributes to maximizing the efficiency and accuracy of cancer data management. The continuing advancements in technology and regulatory support create opportunities for growth within these sectors, making them integral to the market's evolution. Enhanced data analytics and integration capabilities are emerging as key trends, pushing further advancements in cancer care and research across the United States. #### **Cancer Registry Software Market Software Type Insights** The Software Type segment of the US Cancer Registry Software Market reveals significant insights into the preferences and needs of healthcare institutions. Integrated Software brings together various components of cancer registry management, enhancing workflow efficiency and data accuracy, thus playing a vital role in comprehensive patient care. In contrast, Standalone Software provides specialized functions tailored to specific tasks, offering flexibility for smaller organizations that may not require full integration. Custom Software caters to the unique requirements of healthcare facilities, enabling them to address specific challenges within their cancer registries while meeting regulatory standards. Each of these software types supports the broader objectives of cancer tracking and reporting, contributing to improved patient outcomes. The market landscape continues to evolve as technological advancements enhance data analytics capabilities, real-time reporting, and health information accessibility, ultimately fostering an environment conducive to cancer research and treatment innovations. As such, these software types not only support operational efficiencies but also align with ongoing efforts to enhance the quality of cancer care in the US. ### **US Cancer Registry Software Market Key Players and Competitive Insights** The US Cancer Registry Software Market is characterized by a competitive landscape dominated by several key players that leverage advanced technologies to enhance cancer data management and reporting capabilities. As the healthcare industry continually scans for solutions to improve patient outcomes, the demand for efficient, robust, and user-friendly cancer registry software has risen significantly. This demand is underscored by the need to comply with regulatory mandates and to streamline the management of extensive patient and treatment data associated with cancer care. Companies are focused on innovation and investment in research and development to provide comprehensive tools that assist healthcare institutions in tracking, analyzing, and reporting cancer incidences and treatment results effectively. The competition further intensifies as these firms not only compete on technological advancements but also on their ability to offer superior customer service and support. Allscripts commands a significant presence in the US Cancer Registry Software Market by providing an integrated approach to healthcare management, which includes cancer registry capabilities. The strengths of Allscripts lie in its ability to deliver comprehensive electronic health record (EHR) systems that facilitate the collection and reporting of cancer data. Their cloud-based solutions enhance accessibility, allowing registered users to analyze data in real-time and improve patient care. Allscripts is known for its commitment to innovation, regularly updating its software to comply with regulatory requirements, which ensures that healthcare providers can effectively manage cancer registries. The company's strong partnerships within the healthcare ecosystem further allow it to deploy solutions that are tailored to the specific needs of cancer care providers across various settings, thus solidifying its position in the market. Optum, as a part of the UnitedHealth Group, has established a prominent foothold in the US Cancer Registry Software Market by integrating data analytics and technology solutions into its offerings. Known for its comprehensive healthcare services, Optum leverages its extensive resources to provide tools that assist healthcare professionals in the management of patient care and cancer registry operations. The strength of Optum lies in its ability to combine its cancer registry software with broader healthcare analytics capabilities, enabling organizations to derive insights from the data collected effectively. The company is also recognized for its strategic mergers and acquisitions, which have bolstered its technology stack and expanded its service offerings in the realm of cancer treatment and management. Optum’s focus on enhancing interoperability and streamlining processes ensures that healthcare providers can improve their operational efficiency while focusing on patient outcomes and adherence to regulatory standards. ### **Key Companies in the US Cancer Registry Software Market Include** ### **US Cancer Registry Software Market Industry Developments** Recent developments in the US Cancer Registry Software Market have shown notable advancements among key players such as Allscripts, Optum, and Cerner, which have been enhancing their software solutions to better facilitate data collection and reporting for cancer registries. In September 2023, McKesson announced the integration of its cancer registry software with artificial intelligence capabilities, aiming for improved data accuracy and operational efficiency. Similarly, in August 2023, IBM Watson Health collaborated with Roche to integrate advanced analytics into cancer registry tools, allowing for better patient outcomes through tailored treatment plans. As for mergers and acquisitions, in July 2023, Genetec completed the acquisition of a smaller software firm, strengthening its capacity in cancer data management, which has garnered attention from multiple reputable outlets. Growth in this market continues, with analysts noting a projected increase of over 10% in market valuation by the end of 2024, indicating a rising demand for innovative cancer registry solutions driven by regulatory requirements and a focus on precision medicine. Furthermore, major partnerships between CureMD and Siemens Healthineers aimed at enhancing interoperability in registry software are noteworthy developments in the past year. ### **US Cancer Registry Software Market Segmentation Insights** #### **Cancer Registry Software Market Deployment Type Outlook** #### **Cancer Registry Software Market Application Outlook** #### **Cancer Registry Software Market End User Outlook** #### **Cancer Registry Software Market Software Type Outlook** - Integrated Software - Standalone Software - Custom Software ## Market Drivers ### Advancements in Data Analytics The cancer registry-software market is experiencing growth due to advancements in data analytics technologies. Enhanced analytical capabilities allow healthcare providers to derive actionable insights from vast datasets, improving patient care and treatment outcomes. The integration of sophisticated analytics tools into cancer registry software enables users to identify trends, track treatment efficacy, and optimize resource allocation. As healthcare organizations increasingly recognize the value of data-driven decision-making, the demand for software that incorporates advanced analytics is expected to rise. This trend suggests a promising future for the cancer registry-software market, as organizations seek to leverage data for improved healthcare delivery. ### Increasing Cancer Incidence Rates The rising incidence of cancer in the US is a primary driver for the cancer registry-software market. According to the National Cancer Institute, the number of new cancer cases is projected to reach approximately 1.9 million by 2025. This surge necessitates efficient data management and tracking systems, which cancer registry software provides. As healthcare providers and institutions strive to improve patient outcomes, the demand for robust software solutions that can handle large volumes of data is likely to increase. Furthermore, the need for accurate reporting and analysis of cancer trends is essential for public health initiatives, thereby propelling the growth of the cancer registry-software market. ### Integration of Telehealth Services The integration of telehealth services into cancer care is influencing the cancer registry-software market. As telehealth becomes more prevalent, there is a need for software solutions that can seamlessly incorporate data from remote consultations and treatments. This integration allows for comprehensive patient records and enhances the ability to track patient outcomes over time. The cancer registry-software market stands to benefit from this trend, as healthcare providers seek solutions that can adapt to the changing landscape of cancer care. The potential for improved patient engagement and data collection through telehealth initiatives may further stimulate market growth. ### Growing Emphasis on Research and Clinical Trials The cancer registry software market is being propelled by a growing emphasis on research and clinical trials. As the US healthcare landscape evolves, there is an increasing need for comprehensive data to support clinical research initiatives. Cancer registries play a crucial role in providing the necessary data for researchers to evaluate treatment outcomes and develop new therapies. The National Cancer Institute has reported a significant increase in clinical trials, which necessitates efficient data management systems. Consequently, the demand for cancer registry software that can support these research efforts is likely to grow, further driving the market. ### Regulatory Compliance and Reporting Requirements Stringent regulatory frameworks in the US healthcare sector are driving the cancer registry-software market. Organizations are required to comply with various federal and state regulations, including the Cancer Registry Amendment Act, which mandates the collection and reporting of cancer data. Failure to comply can result in significant penalties, thus incentivizing healthcare providers to adopt advanced software solutions. The cancer registry-software market is expected to benefit from this trend, as these systems facilitate compliance by automating data collection and reporting processes. As regulations evolve, the need for adaptable and compliant software solutions will likely become even more pronounced. ## Future Outlook The [Cancer Registry Software Market](https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852) is projected to grow at a 7.11% CAGR from 2025 to 2035, driven by technological advancements, regulatory requirements, and increasing cancer incidence. **New opportunities:** - Integration of AI-driven analytics for enhanced data insights. Development of mobile applications for real-time data entry. Partnerships with healthcare providers for customized solutions. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Deployment Type: Cloud-Based (Largest) vs. On-Premises (Fastest-Growing) In the US cancer registry-software market, the deployment type segment is predominantly led by cloud-based solutions, which have captured a significant share due to their scalability and ease of access. Following closely is the on-premises model, catering to organizations with specific regulatory or security needs. Web-based solutions are also present, but they remain a smaller portion of the market, appealing primarily to smaller entities seeking cost-effective software solutions. Growth trends within this segment are markedly driven by the increasing demand for flexible and scalable options, with cloud-based solutions witnessing the highest adoption rates. The trend is shifting towards online accessibility and collaborative functionalities, prompting hybrid deployments to gain traction. On-premises solutions are gaining momentum as well, particularly among larger healthcare organizations investing in comprehensive systems to handle their data securely. Cloud-Based (Dominant) vs. On-Premises (Emerging) Cloud-based solutions in the US cancer registry-software market offer unmatched flexibility and access, making them dominant in terms of market preference among healthcare organizations. Their ability to integrate with other platforms and provide real-time data significantly enhances patient care and administrative efficiency. On-premises solutions, while emerging, can be seen as tailored systems favored by larger entities that require stringent data security and compliance with regulations. These installations provide increased control over data but often involve higher upfront costs and ongoing maintenance. As organizations navigate this balance between control and convenience, the deployment type landscape is evolving with innovations tailored to meet diverse user needs. ### By Application: Data Management (Largest) vs. Patient Monitoring (Fastest-Growing) In the US cancer registry-software market, Data Management dominates with a significant share, accounting for the largest portion of market activity. This segment ensures that vast amounts of patient data are organized, stored, and easily accessible, which is crucial for healthcare providers in making informed decisions. Meanwhile, Data Collection and Analysis and Reporting play vital roles, but they currently have smaller shares in comparison, reflecting the broader reliance on effective data management processes. Growth trends in the US cancer registry-software market indicate a surge in patient monitoring solutions. As the emphasis on personalized care increases, software that actively tracks patient health metrics is gaining traction among healthcare providers. Moreover, advancements in technology enable more sophisticated data collection and analysis methods, satisfying the need for enhanced patient insights and better treatment outcomes, ultimately driving the growth of patient monitoring tools. Data Management (Dominant) vs. Patient Monitoring (Emerging) Data Management serves as the backbone for effective cancer registry-software functionalities, being essential for maintaining accurate patient data and regulatory compliance. This segment encompasses several activities, including data entry, validation, and reporting, ensuring seamless operations within healthcare institutions. In contrast, Patient Monitoring is an emerging segment that combines technology with healthcare practices, focusing on real-time tracking of patient conditions. Its rise is driven by the increasing demand for remote monitoring solutions, providing healthcare professionals with timely information about their patients. The dynamic advancement in health technology supports the rapid evolution of both segments, creating a competitive landscape between established data management practices and innovative patient monitoring systems. ### By End User: Hospitals (Largest) vs. Cancer Treatment Centers (Fastest-Growing) In the US cancer registry-software market, segment distribution indicates that hospitals hold the largest share, driven by their extensive patient bases and need for comprehensive data management solutions. Research institutions and government organizations also play significant roles but are comparatively smaller in terms of market share. Cancer treatment centers are emerging as vital players, reflecting a growing demand for targeted cancer care solutions. Growth trends show that the segment is influenced by increasing cancer incidences and the rising need for data-driven treatment decisions. Hospitals continue to invest in advanced software solutions to enhance patient outcomes, while cancer treatment centers are rapidly adopting innovative technologies to streamline operations and improve service delivery. This shift positions cancer treatment centers as the fastest-growing segment amidst evolving healthcare landscapes. Hospitals (Dominant) vs. Cancer Treatment Centers (Emerging) Hospitals dominate the US cancer registry-software market due to their substantial operational scale and commitment to integrating sophisticated data management systems that enhance patient care. Their ability to leverage vast amounts of patient data allows for improved clinical decision-making, making them key stakeholders in the market. On the other hand, cancer treatment centers are emerging as vital players, differentiating themselves by focusing on specialized cancer care and personalized treatment plans. The adoption of advanced technology in these centers is accelerating their growth, enabling them to provide targeted solutions that meet the unique needs of cancer patients, making them pivotal in the evolving healthcare landscape. ### By Software Type: Integrated Software (Largest) vs. Standalone Software (Fastest-Growing) In the US cancer registry-software market, Integrated Software holds the largest market share, benefiting from its comprehensive capabilities that allow seamless data integration across multiple applications. Standalone Software, while smaller in share, has been gaining traction due to its specific functionalities that cater to particular user needs, leading to an evolving competitive landscape. Custom Software has a niche presence, often tailored for unique institutional requirements, contributing a steady yet limited share to the market. Growth trends indicate that the demand for Integrated Software remains strong as healthcare institutions aim for unified solutions that enhance efficiency and collaboration in cancer data management. Meanwhile, Standalone Software is seeing a surge in popularity as facilities increasingly prefer solutions that can be implemented quickly without extensive integration processes. In contrast, Custom Software continues to experience stable demand among organizations requiring specialized features for their workflows, despite its slower growth rate. Integrated Software: Dominant vs. Standalone Software: Emerging Integrated Software is characterized by its capacity to unify various functionalities into a single platform, making it the dominant choice for many healthcare organizations looking to streamline operations and improve data interoperability. This software type allows for real-time data sharing and comprehensive reporting, which are vital in cancer registries. On the other hand, Standalone Software is emerging as a useful alternative, offering targeted features that address specific operational needs without the complexities of larger systems. This makes it particularly appealing for smaller practices or departments that may not require the full breadth of features offered by integrated solutions. As the landscape evolves, organizations are increasingly valuing flexibility and customization, allowing both software types to coexist meaningfully in the market. ## Competitive Benchmarking The [cancer registry-software market](https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852) is characterized by a dynamic competitive landscape, driven by the increasing demand for efficient data management and analytics in oncology. Key players such as Cerner Corporation (US), McKesson Corporation (US), and Epic Systems Corporation (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Cerner Corporation (US) focuses on innovation through the integration of advanced analytics and artificial intelligence (AI) into its software solutions, aiming to improve patient outcomes and streamline workflows. Meanwhile, McKesson Corporation (US) emphasizes strategic partnerships and acquisitions to expand its service offerings and enhance its technological capabilities. Epic Systems Corporation (US) is known for its robust electronic health record (EHR) systems, which it continuously updates to include cancer registry functionalities, thereby reinforcing its competitive edge in the market.The business tactics employed by these companies reflect a moderately fragmented market structure, where collaboration and local adaptation are crucial. Companies are increasingly localizing their software solutions to meet specific regulatory requirements and user needs, which enhances their competitive advantage. The collective influence of these key players shapes the market dynamics, as they strive to optimize supply chains and improve service delivery through technological advancements. In August Cerner Corporation (US) announced a partnership with a leading AI firm to develop predictive analytics tools specifically for cancer treatment pathways. This strategic move is expected to enhance the decision-making capabilities of healthcare providers, allowing for more personalized treatment plans. The integration of AI into cancer registry software could potentially revolutionize how data is utilized in clinical settings, thereby improving patient care. In September McKesson Corporation (US) completed the acquisition of a prominent data analytics company, which specializes in oncology data management. This acquisition is likely to bolster McKesson's capabilities in providing comprehensive cancer registry solutions, enabling it to offer more integrated services to healthcare providers. The strategic importance of this move lies in its potential to enhance data interoperability and streamline reporting processes, which are critical in cancer care. In October Epic Systems Corporation (US) launched an updated version of its EHR system that includes enhanced cancer registry functionalities. This update is designed to facilitate better data collection and reporting for oncology practices, thereby improving compliance with national cancer data standards. The strategic significance of this development is that it positions Epic as a leader in the integration of cancer registry capabilities within broader EHR systems, appealing to a wide range of healthcare institutions. As of November the competitive trends in the cancer registry-software market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing service delivery. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on technological innovation, reliability in supply chains, and the ability to provide comprehensive, data-driven solutions for cancer care. ## Recent News & Developments Recent developments in the US Cancer Registry Software Market have shown notable advancements among key players such as Allscripts, Optum, and Cerner, which have been enhancing their software solutions to better facilitate data collection and reporting for cancer registries. In September 2023, McKesson announced the integration of its cancer registry software with artificial intelligence capabilities, aiming for improved data accuracy and operational efficiency. Similarly, in August 2023, IBM Watson Health collaborated with Roche to integrate advanced analytics into cancer registry tools, allowing for better patient outcomes through tailored treatment plans. As for mergers and acquisitions, in July 2023, Genetec completed the acquisition of a smaller software firm, strengthening its capacity in cancer data management, which has garnered attention from multiple reputable outlets. Growth in this market continues, with analysts noting a projected increase of over 10% in market valuation by the end of 2024, indicating a rising demand for innovative cancer registry solutions driven by regulatory requirements and a focus on precision medicine. Furthermore, major partnerships between CureMD and Siemens Healthineers aimed at enhancing interoperability in registry software are noteworthy developments in the past year. ## Report Scope | MARKET SIZE 2024 | 590.82(USD Million) | | --- | --- | | MARKET SIZE 2025 | 632.83(USD Million) | | MARKET SIZE 2035 | 1257.72(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.11% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), IBM Watson Health (US), Oracle Corporation (US), Allscripts Healthcare Solutions (US), Varian Medical Systems (US), Siemens Healthineers (DE) | | Segments Covered | Deployment Type, Application, End User, Software Type | | Key Market Opportunities | Integration of artificial intelligence enhances data accuracy and patient outcomes in the cancer registry-software market. | | Key Market Dynamics | Growing demand for data-driven insights drives innovation in cancer registry-software solutions amid evolving regulatory frameworks. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US cancer registry-software market?** A: The market valuation was $590.82 Million in 2024. **Q: What is the projected market valuation for the US cancer registry-software market by 2035?** A: The projected valuation for 2035 is $1257.72 Million. **Q: What is the expected CAGR for the US cancer registry-software market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.11% during the forecast period. **Q: Which companies are considered key players in the US cancer registry-software market?** A: Key players include Cerner Corporation, McKesson Corporation, Epic Systems Corporation, IBM Watson Health, Oracle Corporation, Allscripts Healthcare Solutions, Varian Medical Systems, and Siemens Healthineers. **Q: What are the main deployment types in the US cancer registry-software market?** A: The main deployment types are On-Premises, Cloud-Based, and Web-Based solutions. **Q: How did the Cloud-Based segment perform in 2024?** A: The Cloud-Based segment was valued at $236.32 Million in 2024 and is projected to reach $515.54 Million. **Q: What applications are covered in the US cancer registry-software market?** A: Applications include Data Collection, Data Management, Analysis and Reporting, and Patient Monitoring. **Q: What was the valuation of the Analysis and Reporting application in 2024?** A: The Analysis and Reporting application was valued at $162.2 Million in 2024. **Q: Which end users are primarily involved in the US cancer registry-software market?** A: End users include Hospitals, Research Institutions, Government Organizations, and Cancer Treatment Centers. **Q: What is the projected growth for the Integrated Software segment by 2035?** A: The Integrated Software segment is projected to grow from $236.33 Million in 2024 to $525.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-cancer-registry-software-market-13801*